FROs are non-profit, impact-driven moonshot initiatives, combining philanthropic support with startup-like agility to tackle humanity's biggest challenges.
Learn more about Imprint:
FROs are non-profit, impact-driven moonshot initiatives, combining philanthropic support with startup-like agility to tackle humanity's biggest challenges.
Learn more about Imprint:
✨IMPRINT is #hiring! ✨
Join us to help revolutionize how we decode the body’s immune memory, uncover the causes of chronic diseases, and drive breakthroughs in autoimmunity and neuropsychiatric research.
#BiotechJobs #Immunology #sciencejobs
✨IMPRINT is #hiring! ✨
Join us to help revolutionize how we decode the body’s immune memory, uncover the causes of chronic diseases, and drive breakthroughs in autoimmunity and neuropsychiatric research.
#BiotechJobs #Immunology #sciencejobs
#Immunology
#Immunology
🐋🌱🧪🦋🦫 #EvoBio
🐋🌱🧪🦋🦫 #EvoBio
#AIRRC7 #Immunology
#AIRRC7 #Immunology
www.biorxiv.org/content/10.1...
We apply assay to characterize response to repeat influenza vaccination
www.biorxiv.org/content/10.1...
We apply assay to characterize response to repeat influenza vaccination
Theory, experiment and data in microbial ecology, evolution and systems biology!
Featuring @saramitri.bsky.social and @seppekuehnlab.bsky.social
#evosky #livingmatter
Theory, experiment and data in microbial ecology, evolution and systems biology!
Featuring @saramitri.bsky.social and @seppekuehnlab.bsky.social
#evosky #livingmatter
We find differences in mutation effects among age groups
Virus seems to evolve especially to escape antibodies of teenagers
www.biorxiv.org/content/10.1...
We find differences in mutation effects among age groups
Virus seems to evolve especially to escape antibodies of teenagers
www.biorxiv.org/content/10.1...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
20% of people assessed had accelerated aging in 1 organ, 1.7% multi-organ
www.nature.com/articles/s41...
20% of people assessed had accelerated aging in 1 organ, 1.7% multi-organ